| Nome |
# |
|
Dietary supplements for lipedema, file 57125daa-710a-4490-a87d-6576cfe4dec7
|
231
|
|
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study., file e14ff6e2-f1a1-0209-e053-6605fe0ad24c
|
143
|
|
Dietary supplements for the management of COVID-19 symptoms, file 7579fa88-6fac-493f-9dea-d75bc59801d8
|
131
|
|
Tailored biological treatment for patients with
moderate-to-severe psoriasis, file 572e8bc3-d6b5-450f-97c5-3fd15b849b68
|
123
|
|
Dermoscopic features of nevoid
melanoma: a retrospective study, file ec982198-bb4a-42cc-b797-b8ad289e0c46
|
97
|
|
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis, file b40f8edc-c6ee-4172-9ae2-f22779994a22
|
78
|
|
Monkeypox virus infection: what dermatologist needs to know?, file 875f895d-314e-4425-9adc-932c99b04274
|
75
|
|
Uncommon Non‑Infectious Annular Dermatoses, file 801ecc9f-7231-4fac-97ce-8e5e6ebbb4a2
|
73
|
|
Psoriasis: talking points from recent clinical trials, file d6b14ef7-2b9b-4aae-9e5f-92bd3993a18a
|
68
|
|
Polymorphisms, diet and nutrigenomics, file a5fbd454-8612-4ab9-97fd-8987f104f03d
|
61
|
|
Atopic Dermatitis in the Elderly Population, file 976d5585-3c80-4e66-b995-07d2682e8e61
|
54
|
|
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis, file ae9d438b-e893-4550-9259-46c4ed6f8489
|
48
|
|
Use of biologics during the COVID-19 pandemic:
lessons learned from psoriasis, file faa0811a-a44c-4aef-a646-134b4c7f80c7
|
41
|
|
Main nutritional deficiencies, file d9fff2f1-b3f2-4532-b20e-6f8efbb4be65
|
37
|
|
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis, file e14ff6e5-d0b8-0209-e053-6605fe0ad24c
|
35
|
|
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma, file a4922823-6942-49fc-a6d1-d4502b5831e8
|
31
|
|
Advanced Glycation End Products and Psoriasis, file ee36b523-0f3a-47a5-be16-dd46eaea53c7
|
28
|
|
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment, file 6370ae43-df4f-4ede-bc63-bddf7d73bd2e
|
26
|
|
The transition from mild to moderate-to-severe chronic plaque psoriasis, file dc44fa6e-b9df-4c3b-bed6-129f8da7c458
|
26
|
|
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro, file fa084398-370f-4a7f-b9e0-80da3d310bcc
|
24
|
|
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study, file 0f79581b-3c90-4997-b3dd-7749e575413b
|
22
|
|
Effects of secukinumab on serum adipocytokines: preliminary data, file e14ff6e4-d080-0209-e053-6605fe0ad24c
|
22
|
|
The Combination of Dupilumab with Other Monoclonal Antibodies, file 7bee7838-9755-4875-ae6d-b42a9dac462e
|
21
|
|
Eosinophilic annular erythema
successfully treated with cyclosporine, file 0d24f4c2-c6ff-4c76-9410-bc354734c8f2
|
18
|
|
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis, file 2c9c4301-087e-450a-9acd-6f14046a496c
|
17
|
|
Il ruolo della vitamina D nella dermatite atopica, file df371fb5-fe8d-4c0e-8b00-7c1bb36d647a
|
17
|
|
Polyphenols and Lactobacillus reuteri in oral health, file 0ec51e47-851b-436e-a3a0-24c5555b5d96
|
16
|
|
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach, file 5a1e9efe-b563-4127-a99a-5e4581864909
|
16
|
|
Cost per responder of adalimumab biosimilars
versus methotrexate in patients with psoriasis: a
real-life experience, file 04be6acc-79a9-4f8f-82ea-c0203ba995d1
|
15
|
|
Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature, file 5dfe580c-80fd-40fa-9380-549d07aafb64
|
15
|
|
Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region, file c88d9e9f-b61c-415d-841f-193d652b9ca6
|
15
|
|
Does systemic treatment of psoriasis reduce the risk of comorbidities?, file 0a69a8ef-409f-43c1-a31b-c8afb272d8b1
|
14
|
|
Cost per responder of Adalimumab biosimilars
MSB11022 and ABP 501 versus the originator and
methotrexate in chronic plaque psoriasis, file f4b12a0d-0fdd-4af0-aa01-fd887a672dca
|
14
|
|
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis, file 82475bed-4d64-4be7-9856-029f06b671f3
|
13
|
|
Characteristics of Patients Experiencing a Flare of Generalized
Pustular Psoriasis: A Multicenter Observational Study, file 14f40899-8a8a-4bf4-9f27-2a86ccf52f49
|
12
|
|
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series, file 21b02853-8084-40e5-9a12-4aa882cd8bb8
|
12
|
|
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study, file bd950f26-8a5c-4041-a894-c3a155365558
|
11
|
|
Long-term follow-up of Zoon balanitis: a retrospective cohort study, file d8d27086-40e7-46db-887d-89774da677ee
|
11
|
|
Scurvy as Presenting Sign of Anorexia Nervosa, file e8f25d70-4ea9-4d61-b970-05bec3200c3a
|
11
|
|
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers, file 45c1c3f8-ff1e-4049-ae1d-1076a05879f8
|
10
|
|
Association between short-term
exposure to environmental air pollution
and atopic dermatitis flare in patients
treated with dupilumab, file 93766722-bf96-4052-899f-ccf7d3c8ce54
|
10
|
|
Insights into {COVID}-19 vaccination in patients with chronic plaque psoriasis on~systemic treatments, file b3107f51-f914-4b9c-a079-e90ea604780e
|
10
|
|
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations, file b686b2fc-2f93-4ea6-9d2d-50689bf457d2
|
10
|
|
Awareness of obesity among patients with psoriasis, file 2f5dc5f1-58f1-47cd-a6af-c1a774c9724a
|
8
|
|
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence, file 8cb8d047-d77f-4679-ac3c-d1a0dd936271
|
8
|
|
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination, file c4a65c24-685b-4889-9ee3-5e7f3bee5bcc
|
8
|
|
Recurrent cutaneous eosinophilic vasculitis
characterized by annular purpuric lesions: A
case report, file e0679c77-b6a4-489c-9576-fcb386475c0d
|
8
|
|
Prevalence of most common skin diseases in Europe: a population‐based study, file e2c3420e-aa08-4853-9748-d2dc6d02a4bb
|
8
|
|
Down-titration of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study, file 1c949f38-7b34-4bff-b1f4-e29a6c602720
|
7
|
|
PSOCUBE, a multidimensional assessment of psoriasis patients as a both clinically/practically sustainable and evidence-based algorithm, file f451baf4-a418-4f01-9905-4a3a00d53a5f
|
7
|
|
Considerations in association studies in dermatoepidemiology, file 48144052-87b9-4599-b1d8-7a5ae1f76a29
|
6
|
|
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis, file 9b677499-4f3d-442a-8a9c-ef7c321c7bc1
|
6
|
|
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists, file e14ff6e5-dcb8-0209-e053-6605fe0ad24c
|
6
|
|
Corymbose Syphilis, file 7cb33c42-9018-4ebf-b454-29702475729c
|
5
|
|
PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy, file e07b9227-1738-4733-965e-670f1fab716c
|
5
|
|
Price variability of TNF-α inhibitor biosimilars among European countries, file ae501b07-8361-47eb-aaba-034718fd591e
|
4
|
|
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review, file b11bcdeb-cc58-4b28-a006-fea3f985067f
|
4
|
|
Place of apremilast in the real-life treatment of patients with plaque psoriasis, file e14ff6e5-86fa-0209-e053-6605fe0ad24c
|
4
|
|
IL-17A inhibitors in patients with chronic plaque psoriasis and
history of malignancy: A case series with systematic literature
review, file e14ff6e5-a6cd-0209-e053-6605fe0ad24c
|
4
|
|
Increasing Access to Effective Systemic Treatments
in Patients with Moderate-to-Severe Psoriasis:
Narrative Review, file 09751733-950b-4003-9143-c3b53ff36f2b
|
3
|
|
Seminars in Research 2013, file 0ba74a00-6da2-4d41-a10a-6de93cfb2d8c
|
3
|
|
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing, file 23639c5d-cf44-41a5-b465-2cf3959efb6a
|
3
|
|
Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting, file 6d0b0fe5-3c96-4867-afd5-db03582fc2e7
|
3
|
|
X-linked genodermatoses from diagnosis to tailored therapy, file 73a7f632-b9ce-4909-abde-be3739cb364a
|
3
|
|
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review, file e14ff6e5-3dcc-0209-e053-6605fe0ad24c
|
3
|
|
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines, file e14ff6e5-d10d-0209-e053-6605fe0ad24c
|
3
|
|
Omics sciences and precision medicine in melanoma, file 73b721f1-cad8-4ab1-8761-b6bf5f93466c
|
2
|
|
Could maternal stress increase the risk of developing psoriasis in the offspring?, file b691421c-78a3-4a45-abc7-7717a54e5288
|
2
|
|
Systemic therapy of psoriasis in diabetic patients, file e14ff6e3-007a-0209-e053-6605fe0ad24c
|
2
|
|
Treatment Approaches to Moderate to Severe Psoriasis, file e14ff6e3-f529-0209-e053-6605fe0ad24c
|
2
|
|
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry, file e14ff6e4-8289-0209-e053-6605fe0ad24c
|
2
|
|
Increased red blood cell distribution width in patients with plaque psoriasis, file e14ff6e5-772a-0209-e053-6605fe0ad24c
|
2
|
|
Predictors of subsequent primary melanoma: a case-control study, file 4581514b-950e-4b15-aede-c8478cf9bd28
|
1
|
|
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis, file 46de0854-fec8-44f4-b68e-b588e734cf4e
|
1
|
|
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis, file 5ce8665b-0ba9-4310-abde-58cd2f3f0176
|
1
|
|
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies, file 90e623bc-2a79-4a32-acac-70256ce4b6e9
|
1
|
|
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis, file 9a70badf-254d-4221-909b-06028058d9d0
|
1
|
|
Investigating psoriasis awareness among patients in Italy: validation of a questionnaire, file e14ff6e3-0d96-0209-e053-6605fe0ad24c
|
1
|
|
Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?, file e14ff6e3-5789-0209-e053-6605fe0ad24c
|
1
|
|
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis, file e14ff6e5-19c1-0209-e053-6605fe0ad24c
|
1
|
|
Risk of Hospitalization and Death From COVID-19 Infection in Patients With Chronic Plaque Psoriasis Receiving a Biologic Treatment and Renal Transplant Recipients in Maintenance Immunosuppressive Treatment, file e14ff6e5-1c36-0209-e053-6605fe0ad24c
|
1
|
|
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks, file e14ff6e5-5446-0209-e053-6605fe0ad24c
|
1
|
|
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome, file e14ff6e5-6e83-0209-e053-6605fe0ad24c
|
1
|
|
Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients, file e14ff6e5-7251-0209-e053-6605fe0ad24c
|
1
|
|
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study, file e14ff6e5-9f74-0209-e053-6605fe0ad24c
|
1
|
|
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature, file e14ff6e5-b529-0209-e053-6605fe0ad24c
|
1
|
|
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature, file e14ff6e5-b754-0209-e053-6605fe0ad24c
|
1
|
|
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis, file e14ff6e5-eeb0-0209-e053-6605fe0ad24c
|
1
|
| Totale |
1.909 |